Abstract:Previous studies have demonstrated that osteopontin (OPN) levels are elevated in the synovial fluid and articular cartilage, and are associated with the severity of knee osteoarthritis (OA). However, the role of OPN in the pathogenesis of OA has yet to be elucidated. The present study aimed to investigate the effects of OPN on the expression of the aggrecanases, a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)4 and ADAMTS5, in human OA chondrocytes, as they serve a key function in aggrecan degradation. Human OA chondrocytes were obtained from the knees of 16 patients with OA, and subsequently cultured in a monolayer. The chondrocytes were divided into three groups, which included the control (no treatment), N-OPN (treated with 100 ng/ml OPN, the normal circulating OPN concentration) and the H-OPN groups (treated with 1 mu g/ml OPN, a high OPN concentration). Reverse transcription-quantitative polymerase chain reaction was performed to quantify the relative mRNA expression levels of ADAMTS4, ADAMTS5 and aggrecan in the chondrocytes. The mRNA expression levels of ADAMTS4 were significantly reduced in the N-OPN and H-OPN groups when compared with the control group (P<0.0001). In addition, the mRNA expression levels of ADAMTS4 were lower in the H-OPN group when compared with the N-OPN group (P<0.001). However, no statistically significant difference was observed in the relative mRNA expression levels of ADAMTS5 among the three groups (P>0.05). Furthermore, the mRNA expression levels of aggrecan were higher in the N-OPN and H-OPN groups when compared with the control group (P<0.0001), and a statistically significant difference was observed between the N-OPN and H-OPN groups with regard to the mRNA expression of aggrecan (P<0.0001). These results demonstrated that OPN may exert a protective effect in human OA chondrocytes against aggrecan degradation by suppressing the expression of ADAMTS4.

Osteopontin Promotes Expression of Matrix Metalloproteinase 13 Through NF-κB Signaling in Osteoarthritis

[Effect of Osteopontin on Expression of Matrix Metalloproteinase 13 in Human Knee Osteoarthritic Chondrocytes].

Activation of the P38/CREB/MMP 13 Axis is Associated with Osteoarthritis

Phosphorylation of osteopontin in osteoarthritis degenerative cartilage and its effect on matrix metalloprotease 13

Role of osteopontin in induction of monocyte chemoattractant protein 1 and macrophage inflammatory protein 1β through the NF-κB and MAPK pathways in rheumatoid arthritis

Osteopontin promotes inflammation in patients with acute coronary syndrome through its activity on IL-17 producing cells.

Phosphorylation of Osteopontin Has Proapoptotic and Proinflammatory Effects on Human Knee Osteoarthritis Chondrocytes

Osteopontin Activates Retinal Microglia Causing Retinal Ganglion Cells Loss Via P38 MAPK Signaling Pathway in Glaucoma.

Role of Osteopontin in Amplification and Perpetuation of Rheumatoid Synovitis

Increased expression of osteopontin in subchondral bone promotes bone turnover and remodeling, and accelerates the progression of OA in a mouse model

Effect Of Osteopontin On The Mrna Expression Of Adamts4 And Adamts5 In Chondrocytes From Patients With Knee Osteoarthritis

The Effect of Osteopontin on Microglia

Role of Osteopontin in Synovial Th17 Differentiation in Rheumatoid Arthritis.

Osteopontin induces vascular endothelial growth factor expression in articular cartilage through PI3K/AKT and ERK1/2 signaling

Osteopontin stimulates matrix metalloproteinase expression through the nuclear factor-κB signaling pathway in rat temporomandibular joint and condylar chondrocytes.

Osteopontin Acts As a Negative Regulator of Autophagy Accelerating Lipid Accumulation During the Development of Nonalcoholic Fatty Liver Disease

Expression of NF-κB and Osteopontin of Synovial Fluid of Patients with Knee Osteoarthritis.

The pro-inflammatory effect of NR4A3 in osteoarthritis

Osteopontin Affects the Persistence of Beta-Glucan-induced Hepatic Granuloma Formation and Tissue Injury Through Two Distinct Mechanisms.

NEAT1/miR-181c Regulates Osteopontin (OPN)-Mediated Synoviocyte Proliferation in Osteoarthritis.

Advanced oxidation protein products increase TNF-α and IL-1β expression in chondrocytes via NADPH oxidase 4 and accelerate cartilage degeneration in osteoarthritis progression